Screening saves lives. Tracking screening saves practices.
OB/GYN sits at the intersection of two of the highest-impact HEDIS measures: breast cancer screening and cervical cancer screening. For many women, you are the primary point of contact for preventive care. Add prenatal care quality, postpartum follow-up, and contraceptive management, and you are managing some of the most trackable — and financially consequential — care gaps in value-based care.
Glance tracks mammography and Pap/HPV screening compliance, prenatal visit schedules, pregnancy-specific reference ranges, and postpartum care gap closure across your entire patient panel.
Schedule a Demo See FeaturesWomen's health analytics for value-based care
Screening measures are among the most directly actionable in HEDIS — and OB/GYN practices are uniquely positioned to close these gaps at scale.
Breast Cancer Screening (BCS)
Track mammography completion for all women ages 50-74 in your panel. Identify patients overdue for screening, those who have never had a mammogram, and those with abnormal results requiring follow-up. Generate outreach lists sorted by time since last screen. Claims data confirms screening completion even when done at outside facilities.
Cervical Cancer Screening (CCS)
Track Pap smear and HPV co-testing compliance for women ages 21-64. Support both the 3-year Pap cycle (ages 21-29) and 5-year co-testing cycle (ages 30-64). Identify patients due for screening, those with prior abnormal results requiring closer surveillance, and those lost to follow-up after ASCUS or LSIL results.
Prenatal Care Tracking
Track prenatal visit schedules against ACOG guidelines. Identify patients behind on their visit cadence, those with overdue prenatal labs (first trimester screen, GBS, glucose tolerance), and those approaching delivery milestones. Prenatal reference ranges for hemoglobin, platelets, thyroid, and glucose automatically adjusted by trimester.
Pregnancy Reference Ranges
Lab values shift dramatically in pregnancy. Glance provides trimester-specific reference ranges for CBC, thyroid function, renal function, liver enzymes, and coagulation studies. No more manually interpreting a "low" hemoglobin that is actually normal for 32 weeks gestation.
Financial & Quality Analytics
Screening measures are among the most heavily weighted in quality programs. Track your BCS and CCS rates against HEDIS benchmarks, model the revenue impact of improving screening rates by 5%, and identify which outreach strategies yield the highest gap closure rates for your practice.
